Complexities associated with health technology assessments of pharmacogenetic testing: a case study of genotyping for cytochrome P2D6 for the management of women with breast cancer treated with tamoxifen

N Fleeman; K Payne; C Sabridos; R Dickson

Complexities associated with health technology assessments of pharmacogenetic testing: a case study of genotyping for cytochrome P2D6 for the management of women with breast cancer treated with tamoxifen

N Fleeman, K Payne, C Sabridos, R Dickson

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Personalized Medicine
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{787ec41015aa40f590789f38f6aa409c,

title = "Complexities associated with health technology assessments of pharmacogenetic testing: a case study of genotyping for cytochrome P2D6 for the management of women with breast cancer treated with tamoxifen",

author = "N Fleeman and K Payne and C Sabridos and R Dickson",

year = "2013",

language = "English",

journal = "Personalized Medicine",

issn = "1741-0541",

publisher = "Taylor & Francis",

}

TY - JOUR

T1 - Complexities associated with health technology assessments of pharmacogenetic testing: a case study of genotyping for cytochrome P2D6 for the management of women with breast cancer treated with tamoxifen

AU - Fleeman, N

AU - Payne, K

AU - Sabridos, C

AU - Dickson, R

PY - 2013

Y1 - 2013

M3 - Article

SN - 1741-0541

JO - Personalized Medicine

JF - Personalized Medicine

ER -